Methicillin-resistant Staphylococcus aureus infections in children.
Methicillin-resistant Staphylococcus aureus (MRSA) infections are an emerging problem in both children and adults throughout the United States. Skin and soft tissue infections are most common, however serious invasive disease can occur and may involve any anatomic site. The initial empiric therapy of suspected S. aureus infections will be influenced by the regional antimicrobial susceptibility patterns for the organism as well as the severity of the infection being treated. This article will review the epidemiology, clinical features, and treatment considerations for MRSA infections in children.
Swanson
Douglas S
DS
Department of Pediatrics, University of Missouri-Kansas City School of Medicine, USA.
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D008297:Male; D016106:Methicillin Resistance; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D008923:Missouri / Q000453:epidemiology; D018570:Risk Assessment; D012720:Severity of Illness Index; D017192:Skin Diseases, Bacterial / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D018461:Soft Tissue Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D013203:Staphylococcal Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000302:isolation & purification; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents